Skip to main content
SpringerLink
Log in

Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The optimal coronary revascularization strategy for patients with diabetes and left main and/or multivessel disease is undetermined. The aim of our study was to evaluate percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) in those patients. We identified 13 articles, published before October 2011, enrolling 6992 patients, whose follow-up period ranged from 1 to 5 years. Patients with PCI had a significant reduction in cerebral vascular attack (CVA) (OR, 0.29; 95 % CI, 0.16–0.51; p < 0.0001, I 2 = 0 %) as compared with CABG, whereas there was a fourfold increased risk of repeat revascularization associated with PCI even using drug-eluting stent (OR, 4.44; 95 % CI, 3.42–5.78; Χ2 = 4.92, p < 0.00001, I 2 = 0 %). The overall mortality (OR, 0.97; 95 % CI, 0.81–1.15; p = 0.70, I 2 = 0 %) was comparable between the PCI and CABG. However, in subgroup analysis, the composite outcome (death/myocardial infarction/CVA) was significantly reduced in favor of DES implantation (OR, 0.79; 95 % CI, 0.63–0.99; Χ2 = 1.07, p = 0.04, I 2 = 0 %). Our study confirmed the cerebral vascular benefits of PCI by significantly reducing CVA risks, and the composite outcome was better in patients undergoing PCI with drug-eluting stent, despite a higher repeat revascularization rate. It poses imperative demands for future prospective randomized studies to define the optimal strategy in patients with diabetes and left main and/or multivessel disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Harris MI (1998) Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21(Suppl 3):C11–C14

    PubMed  Google Scholar 

  2. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–2038

    Article  PubMed  CAS  Google Scholar 

  3. Daemen J, Kuck KH, Macaya C et al (2008) ARTS-II investigators. Multivessel stenting in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (arterial revascularization therapies study-part II) trial. J Am Coll Cardiol 52:1957–1967

    Article  PubMed  Google Scholar 

  4. Nicholls SJ, Tuzcu EM, Kalidindi S et al (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255–262

    Article  PubMed  CAS  Google Scholar 

  5. Abizaid A, Costa MA, Centemero M et al (2001) Arterial revascularization therapy study group. clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the arterial revascularization therapy study (ARTS) trial. Circulation 104:533–538

    Article  PubMed  CAS  Google Scholar 

  6. Flaherty JD, Davidson CJ (2005) Diabetes and coronary revascularization. JAMA 293:1501–1508

    Article  PubMed  CAS  Google Scholar 

  7. Wijns W, Kolh P, Danchin N et al (2010) On behalf of task force on myocardial revascularization of the european society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS); European association for percutaneous cardiovascular interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555

    Article  PubMed  Google Scholar 

  8. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) On behalf of American College of Cardiology/American Heart Association Task Force on Practice Guidelines, American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to Update the 2001 guidelines for percutaneous coronary intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47:216–235

    Article  PubMed  Google Scholar 

  9. Serruys PW, Morice MC, Kappetein AP et al (2009) SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972

    Article  PubMed  CAS  Google Scholar 

  10. Kapur A, Hall RJ, Malik IS et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDIA (coronary artery revascularization in diabetes) trial. J Am Coll Cardiol 55:432–440

    Article  PubMed  Google Scholar 

  11. Stroup DF, Berlin JA, Morton SE et al (2000) Meta-analysis of observational studies in epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012

    Article  PubMed  CAS  Google Scholar 

  12. Moher D, Cook J, Eastwood S et al (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354:1896–1900

    Article  PubMed  CAS  Google Scholar 

  13. Tarantini G, Ramondo A, Napodano M et al (2009) PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc Int 73:50–58

    Article  Google Scholar 

  14. Briguori C, Condorelli G, Airoldi F et al (2007) Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 99:779–784

    Article  PubMed  CAS  Google Scholar 

  15. Lee MS, Jamal F, Kedia G et al (2007) Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol 123:34–42

    Article  PubMed  Google Scholar 

  16. Qiao Y, Ma C, Nie S et al (2009) Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease. Clin Cardiol 32:E24–E30

    Article  PubMed  Google Scholar 

  17. Gwon HC, Choi SH, Choi BI et al (2005) KORR Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean multicenter revascularization registry (KORR). J Korean Med Sci 20(2):196–203

    Article  PubMed  Google Scholar 

  18. Domínguez-Franco AJ, Jiménez-Navarro MF, Hernández-García JM et al (2009) Comparison of medium-term outcomes obtained with drug-eluting stents and coronary artery bypass grafts in an unselected population of diabetic patients with multivessel coronary disease.Propensity score analysis. Rev Esp Cardiol 62(5):491–500

    Article  PubMed  Google Scholar 

  19. Kim WJ, Park DW, Yun SC et al (2009) Impact of diabetes mellitus on the treatment effect of percutaneous or surgical revascularization for patients with unprotected left main coronary artery disease: a subgroup analysis of the MAIN-COMPARE study. JACC Cardiovasc Interv 2(10):956–963

    Article  PubMed  Google Scholar 

  20. Banning AP, Westaby S, Morice MC et al (2010) Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 55(11):1067–1075

    Article  PubMed  CAS  Google Scholar 

  21. Kapur A, Bartolini D, Finlay MC et al (2010) The bypass angioplasty revascularization in Type 1 and Type 2 diabetes study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. J Cardiovasc Med (Hagerstown) 11(1):26–33

    Article  Google Scholar 

  22. Yamagata K, Kataoka Y, Kokubu N et al (2010) A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 74(4):671–678

    Article  PubMed  CAS  Google Scholar 

  23. Park DW, Kim YH, Song HG et al (2011) Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan medical center-multivessel revascularization registry. J Am Coll Cardiol 57(2):128–137

    Article  PubMed  Google Scholar 

  24. Lee MS, Yang T, Dhoot J et al (2010) Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol 105(11):1540–1544

    Article  PubMed  Google Scholar 

  25. Capodanno D, Stone GW, Morice MC et al (2011) Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 58:1426–1432

    Article  PubMed  Google Scholar 

  26. Aronson D, Edelman ER (2010) Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord 11(1):75–86

    Article  PubMed  Google Scholar 

  27. Antunes PE, de Oliveira JF, Antunes MJ (2008) Coronary surgery in patients with diabetes mellitus: a risk-adjusted study on early outcome. Eur J Cardiothorac Surg 34:370–375

    Article  PubMed  Google Scholar 

  28. Newman MF, Kirchner JL, Phillips-Bute B et al (2001) Neurological outcome research group and the cardiothoracic anesthesiology research endeavors investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344:395–402

    Article  PubMed  CAS  Google Scholar 

  29. Egger M, Schneider M, Davey Smith G (1998) Spurious precision? Meta-analysis of observational studies. BMJ 316:140–144

    Article  PubMed  CAS  Google Scholar 

  30. Tarantini G, Lanzellotti D (2010) Three-vessel coronary disease in diabetics: personalized versus evidence-based revascularization strategy. Future Cardiol 6(6):797–809

    Article  PubMed  Google Scholar 

  31. Farkouh ME, Dangas G, Leon MB et al (2008) Design of the future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial. Am Heart J 155:215–223

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

None.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Cardiology, An Zhen Hospital, Capital Medical University, Anzhenli Avenue, Chao Yang District, Beijing, 100029, China

    Fei Gao, Yu Jie Zhou, Hua Shen, Zhi Jian Wang, Shi Wei Yang & Xiao Li Liu

Authors
  1. Fei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Jie Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hua Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhi Jian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shi Wei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao Li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu Jie Zhou.

Additional information

Communicated by Guido Pozza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, F., Zhou, Y.J., Shen, H. et al. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease. Acta Diabetol 50, 765–773 (2013). https://doi.org/10.1007/s00592-012-0411-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-012-0411-4

Keywords

Search

Navigation